Cargando…
Optimal Antiviral Switching to Minimize Resistance Risk in HIV Therapy
The development of resistant strains of HIV is the most significant barrier to effective long-term treatment of HIV infection. The most common causes of resistance development are patient noncompliance and pre-existence of resistant strains. In this paper, methods of antiviral regimen switching are...
Autores principales: | Luo, Rutao, Piovoso, Michael J., Martinez-Picado, Javier, Zurakowski, Ryan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207836/ https://www.ncbi.nlm.nih.gov/pubmed/22073250 http://dx.doi.org/10.1371/journal.pone.0027047 |
Ejemplares similares
-
HIV Model Parameter Estimates from Interruption Trial Data including Drug Efficacy and Reservoir Dynamics
por: Luo, Rutao, et al.
Publicado: (2012) -
Modelling HIV-1 2-LTR dynamics following raltegravir intensification
por: Luo, Rutao, et al.
Publicado: (2013) -
HIV 2-LTR experiment design optimization
por: Cannon, LaMont, et al.
Publicado: (2018) -
Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence
por: Martinez-Picado, Javier, et al.
Publicado: (2018) -
An Integrated Spatial Dynamics—Pharmacokinetic Model Explaining Poor Penetration of Anti-retroviral Drugs in Lymph Nodes
por: Jagarapu, Aditya, et al.
Publicado: (2020)